malondialdehyde has been researched along with Hematologic Malignancies in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberola, J; García Giménez, JL; Giménez, E; Navarro, D; Pallardó, FV; Solano, C; Talaya, A; Vinuesa, V | 1 |
| Bergman, V; Leanderson, P; Starkhammar, H; Tagesson, C | 1 |
2 other study(ies) available for malondialdehyde and Hematologic Malignancies
| Article | Year |
|---|---|
Assessing the risk of cytomegalovirus DNAaemia in allogeneic stem cell transplant recipients by monitoring oxidative-stress markers in plasma.
Topics: Adult; Aged; Antioxidants; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Glutathione; Hematologic Neoplasms; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Protein Carbonylation; ROC Curve; Stem Cell Transplantation; Viral Load; Viremia | 2017 |
Urinary excretion of 8-hydroxydeoxyguanosine and malondialdehyde after high dose radiochemotherapy preceding stem cell transplantation.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxyguanosine; Drug Therapy; Female; Hematologic Neoplasms; Humans; Leukocyte Count; Male; Malondialdehyde; Middle Aged; Stem Cell Transplantation; Transplantation Conditioning; Whole-Body Irradiation | 2004 |